Girls Play Trumpets Too, an inspiring organization dedicated to empowering young female musicians, is excited to announce its first-ever open house. This event will take place at the New Orleans ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback